Literature DB >> 22961867

A differing role of oxidative stress in the regulation of central and peripheral hemodynamics during exercise in heart failure.

Melissa A H Witman1, John McDaniel, Anette S Fjeldstad, Stephen J Ives, Jia Zhao, Jose N Nativi, Josef Stehlik, D Walter Wray, Russell S Richardson.   

Abstract

This study sought to characterize the role of free radicals in regulating central and peripheral hemodynamics at rest and during exercise in patients with heart failure (HF). We examined cardiovascular responses to dynamic handgrip exercise (4, 8, and 12 kg at 1 Hz) following consumption of either a placebo or acute oral antioxidant cocktail (AOC) consisting of vitamin C, E, and α-lipoic acid in a balanced, crossover design. Central and peripheral hemodynamics, mean arterial pressure, cardiac index, systemic vascular resistance (SVR), brachial artery blood flow, and peripheral (arm) vascular resistance (PVR) were determined in 10 HF patients and 10 age-matched controls. Blood assays evaluated markers of oxidative stress and efficacy of the AOC. When compared with controls, patients with HF exhibited greater oxidative stress, measured by malondialdehyde (+36%), and evidence of endogenous antioxidant compensation, measured by greater superoxide dismutase activity (+83%). The AOC increased plasma ascorbate (+50%) in both the HF patients and controls, but significant systemic hemodynamic effects were only evident in the patients with HF, both at rest and throughout exercise. Specifically, the AOC reduced mean arterial pressure (-5%) and SVR (-12%) and increased cardiac index (+7%) at each workload. In contrast, peripherally, brachial artery blood flow and PVR (arm) were unchanged by the AOC. In conclusion, these data imply that SVR in patients with HF is, at least in part, mediated by oxidative stress. However, this finding does not appear to be the direct result of muscle-specific changes in PVR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961867      PMCID: PMC3517640          DOI: 10.1152/ajpheart.00568.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  50 in total

1.  Non-invasive assessment of cardiac output during exercise in healthy young humans: comparison between Modelflow method and Doppler echocardiography method.

Authors:  J Sugawara; T Tanabe; M Miyachi; K Yamamoto; K Takahashi; M Iemitsu; T Otsuki; S Homma; S Maeda; R Ajisaka; M Matsuda
Journal:  Acta Physiol Scand       Date:  2003-12

2.  Plasma norepinephrine in congestive heart failure.

Authors:  J A Thomas; B H Marks
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

3.  Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase.

Authors:  Ulf Landmesser; Stephan Spiekermann; Sergey Dikalov; Helma Tatge; Ragna Wilke; Christoph Kohler; David G Harrison; Burkhard Hornig; Helmut Drexler
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

Review 4.  Static (isometric) exercise and the heart: physiological and clinical considerations.

Authors:  J H Mitchell; K Wildenthal
Journal:  Annu Rev Med       Date:  1974       Impact factor: 13.739

5.  A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure.

Authors:  R Zelis; J Longhurst; R J Capone; D T Mason
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

6.  Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

Authors:  J A Franciosa; M Park; T B Levine
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

7.  Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase.

Authors:  Lie Gao; Wei Wang; Yu-Long Li; Harold D Schultz; Dongmei Liu; Kurtis G Cornish; Irving H Zucker
Journal:  Circ Res       Date:  2004-09-30       Impact factor: 17.367

8.  Increased endothelin-1 production in patients with chronic heart failure.

Authors:  John D Parker; Jake J Thiessen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03       Impact factor: 4.733

9.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Authors:  Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Stuart Pocock
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

10.  Correction of cardiac output obtained by Modelflow from finger pulse pressure profiles with a respiratory method in humans.

Authors:  Enrico Tam; Marcel Azabji Kenfack; Michela Cautero; Federic Lador; Guglielmo Antonutto; Pietro Enrico di Prampero; Guido Ferretti; Carlo Capelli
Journal:  Clin Sci (Lond)       Date:  2004-04       Impact factor: 6.124

View more
  12 in total

Review 1.  Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction.

Authors:  D Walter Wray; Markus Amann; Russell S Richardson
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

2.  Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction.

Authors:  Kanokwan Bunsawat; Stephen M Ratchford; Jeremy K Alpenglow; Soung Hun Park; Catherine L Jarrett; Josef Stehlik; Stavros G Drakos; Russell S Richardson; D Walter Wray
Journal:  Exp Physiol       Date:  2020-06-18       Impact factor: 2.969

Review 3.  Healthful aging mediated by inhibition of oxidative stress.

Authors:  Stephen F Vatner; Jie Zhang; Marko Oydanich; Tolga Berkman; Rotem Naftalovich; Dorothy E Vatner
Journal:  Ageing Res Rev       Date:  2020-10-19       Impact factor: 10.895

4.  Influence of exercise on oxidative stress in patients with heart failure.

Authors:  Sabrina Weiss Sties; Leonardo Vidal Andreato; Tales de Carvalho; Ana Inês Gonzáles; Vitor Giatte Angarten; Anderson Zampier Ulbrich; Lourenço Sampaio de Mara; Almir Schmitt Netto; Edson Luiz da Silva; Alexandro Andrade
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

5.  Heart failure and movement-induced hemodynamics: partitioning the impact of central and peripheral dysfunction.

Authors:  Melissa A H Witman; Stephen J Ives; Joel D Trinity; H Jonathan Groot; Josef Stehlik; Russell S Richardson
Journal:  Int J Cardiol       Date:  2014-10-22       Impact factor: 4.164

6.  Locomotor Muscle Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Michael A Francisco; Joshua F Lee; Zachary Barrett-O'Keefe; H Jonathan Groot; Stephen M Ratchford; Kanokwan Bunsawat; Jeremy K Alpenglow; John J Ryan; Jose N Nativi; Russell S Richardson; D Walter Wray
Journal:  Hypertension       Date:  2021-11-01       Impact factor: 10.190

7.  α-Lipoic acid ameliorates mitochondrial impairment and reverses apoptosis in FABP3-overexpressing embryonic cancer cells.

Authors:  Lijuan Zhou; Jin Jin; Guixian Song; Hailang Liu; Ming Liu; Chunmei Shi; Lingmei Qian
Journal:  J Bioenerg Biomembr       Date:  2013-03-28       Impact factor: 2.945

8.  The Mechanoreflex and Hemodynamic Response to Passive Leg Movement in Heart Failure.

Authors:  Stephen J Ives; Markus Amann; Massimo Venturelli; Melissa A H Witman; H Jonathan Groot; D Walter Wray; David E Morgan; Josef Stehlik; Russell S Richardson
Journal:  Med Sci Sports Exerc       Date:  2016-03       Impact factor: 5.411

Review 9.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

10.  Inflammation and oxidative stress in heart failure: effects of exercise intensity and duration.

Authors:  G A Ribeiro-Samora; L A Rabelo; A C C Ferreira; M Favero; G S Guedes; L S M Pereira; V F Parreira; R R Britto
Journal:  Braz J Med Biol Res       Date:  2017-08-07       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.